Journal Mobile Options
Table of Contents
Vol. 113, No. 4, 2009
Issue release date: July 2009
Cardiology 2009;113:291–298

Fibronectin Gene Expression in Aortic Regurgitation: Relative Roles of Mitogen-Activated Protein Kinases

Truter S.L. · Catanzaro D.F. · Supino P.G. · Gupta A. · Carter J. · Ene A.R. · Herrold E.M. · Dumlao T.F. · Beltran F. · Borer J.S.
aWyeth Research, Collegeville, Pa., bThe Division of Cardiovascular Medicine and The Howard Gilman Institute for Heart Valve Disease, State University of New York Downstate Medical Center, Brooklyn, N.Y., cColumbia University Medical Center, New York, N.Y., and dBoston Medical Center, South Boston, Mass., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Objectives: In aortic regurgitation (AR), fibronectin (FN) expression is upregulated. This study sought to determine signal transduction pathways involved in upregulation of FN expression in AR. Methods: Cardiac fibroblasts (CF) from rabbits with surgically induced AR and matched controls (NL) were cultured and assayed for FN expression and kinase activity with and without inhibitors of kinases JNK, p38 mitogen-activated protein kinase (MAPK) and extracellular response kinase (ERK). NL CF also were subjected to cyclic strain mimicking AR for 24 h in culture with and without inhibitors. Results: AR CF exhibited 2.9-fold greater c-Jun phosphorylation (p < 0.01) and 1.5- to 2-fold greater ATF2 phosphorylation (p < 0.05–0.01) than NL. JNK and p38MAPK inhibition reduced c-Jun and ATF2 phosphorylation to NL; ERK inhibition had no effect. FN mRNA expression was similar in pattern to kinase activities. Cyclic strain in NL CF increased c-Jun phosphorylation 2-fold versus unstrained controls (p < 0.005). This was suppressed by inhibition of JNK but not p38MAPK. Conclusion: FN expression in response to the acute mechanical strain resembling AR is upregulated primarily via JNK. However, in chronic AR both JNK and p38MAPK are involved. These signaling pathways represent potential therapeutic targets for normalizing extracellular matrix (ECM) composition and contractile force transmission, believed to be related to ECM composition/organization, in AR.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Krayenbuehl HP, Hess OM, Monrad ES, Schneider J, Mall G, Turina M: Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation 1989;79:744–755.
  2. Schwarz F, Flameng W, Schaper J, Langebartels F, Sesto M, Hehrlein F, Schlepper M: Myocardial structure and function in patients with aortic valve disease and their relation to postoperative results. Am J Cardiol 1978;41:661–669.
  3. Fuster V, Danielson MA, Robb RA, Broadbent JC, Brown AL Jr, Elveback LR: Quantitation of left ventricular myocardial fiber hypertrophy and interstitial tissue in human hearts with chronically increased volume and pressure overload. Circulation 1977;55:504–508.
  4. Weber KT, Brilla CG, Janicki JS, Reddy HK, Campbell SE: Myocardial fibrosis: role of ventricular systolic pressure, arterial hypertension, and circulating hormones. Basic Res Cardiol 1991;86(suppl 3):25–31.

    External Resources

  5. Borer J, Truter S, Herrold E, Falcone D, Pena M, Carter J, Dumlao T, Lee J, Supino P: Myocardial fibrosis in chronic aortic regurgitation: molecular and cellular responses to volume overload. Circulation 2002;105:1837–1842.
  6. Goldfine S, Pena M, Magid N, Liu S, Borer J: Myocardial collagen in cardiac hypertrophy resulting from chronic aortic regurgitation. Am J Ther 1998;5:139–146.
  7. Borer J, Pena M, Falcone D, Truter S, Goldfine S: Chronic aortic regurgitation causes fibrosis featuring hyper-production of non-collagen, glucosamine-containing matrix elements. J Am Coll Cardiol 1999;33:562A.
  8. Ruwhof C, van der Laarse A: Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. Cardiovasc Res 2000;47:23–37.
  9. MacKenna D, Dolfi F, Vuori K, Ruoslahti E: Extracellular signal-regulated kinase and c-Jun NH2-terminal kinase activation by mechanical stretch is integrin-dependent and matrix-specific in rat cardiac fibroblasts. J Clin Invest 1998;101:301–310.
  10. Gruden G, Zonca S, Hayward A, Thomas S, Maestrini S, Gnudi L, Viberti GC: Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes 2000;49:655–661.
  11. Lee A, Delhaas T, McCullogh A, Villareal F: Differential responses of adult cardiac fibroblasts to in vitro biaxial strain patterns. J Mol Cell Cardiol 1999;31:1833–1843.
  12. Magid N, Opio G, Wallerson D, Young M, Borer J: Heart failure due to chronic experimental aortic regurgitation. Am J Physiol 1994;267:H556–H562.
  13. Mitra R, Morad M: A uniform enzymatic method for dissociation of myocytes from hearts and stomachs of vertebrates. Am J Physiol 1985;249:H1056–H1060.
  14. Brilla CG, Zhou G, Matsubara L, Weber KT: Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 1994;26:809–820.
  15. Eghbali M, Tomek R, Woods C, Bhambi B: Cardiac fibroblasts are predisposed to convert into myocyte phenotype: specific effect of TGFb. Proc Natl Acad Sci USA 1991;88:795–799.
  16. Peterson GL: Determination of total protein. Methods Enzymol 1983;91:95–119.
  17. Kyriakis J, Avruch J: Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem 1996;271:24313–24316.
  18. Bennett BL, Sasaki DT, Murray BW, O’Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW: SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 2001;98:13681–13686.
  19. Mocanu MM, Baxter GF, Yue Y, Critz SD, Yellon DM: The p38 MAPK inhibitor, SB203580, abrogates ischaemic preconditioning in rat heart but timing of administration is critical. Basic Res Cardiol 2000;95:472–478.
  20. Strohm C, Barancik T, Bruhl ML, Kilian SA, Schaper W: Inhibition of the ER-kinase cascade by PD98059 and UO126 counteracts ischemic preconditioning in pig myocardium. J Cardiovasc Pharmacol 2000;36:218–229.
  21. Schaffer J, Rizen M, L’Italien G, Benbrahim A, Megerman J, Gerstenfeld L, Gray M: Device for the application of a dynamic biaxially uniform and isotropic strain to a flexible cell culture membrane. J Orthop Res 1994;12:709–719.
  22. Alonso CR, Pesce CG, Kornblihtt AR: The CCAAT-binding proteins CP1 and NF-I cooperate with ATF-2 in the transcription of the fibronectin gene. J Biol Chem 1996;271:22271–22279.
  23. Karin M: Mitogen-activated protein kinase cascades as regulators of stress responses. Ann NY Acad Sci 1998;851:139–146.
  24. Atance J, Yost MJ, Carver W: Influence of the extracellular matrix on the regulation of cardiac fibroblast behavior by mechanical stretch. J Cell Physiol 2004;200:377–386.
  25. Herrold E, Carter J, Borer J: Volume overload related shape change limits mass increase with wall thickening but only minimally reduce wall stress. Comput Cardiol 1992;287–290.

    External Resources

  26. Herrold E, Goldfine S, Magid N, Borer J: Myocardial blood flow in aortic regurgitation: computer-based prediction from wall stress compared with fluorescent microsphere measurements. Comput Cardiol 1994;729–732.
  27. Verrecchia F, Wagner EF, Mauviel A: Distinct involvement of the Jun-N-terminal kinase and NF-kappaB pathways in the repression of the human COL1A2 gene by TNF-alpha. EMBO Rep 2002;3:1069–1074.
  28. Verrecchia F, Tacheau C, Wagner EF, Mauviel A: A central role for the JNK pathway in mediating the antagonistic activity of pro-inflammatory cytokines against transforming growth factor-beta-driven SMAD3/4-specific gene expression. J Biol Chem 2003;278:1585–1593.
  29. Wang J, Seth A, McCulloch CA: Force regulates smooth muscle actin in cardiac fibroblasts. Am J Physiol Heart Circ Physiol 2000;279:H2776–H2785.
  30. Ringrose L, Paro R: Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins. Annu Rev Genet 2004;38:413–443.
  31. Petrov VV, Fagard RH, Lijnen PJ: Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac fibroblasts to myofibroblasts. Hypertension 2002;39:258–263.
  32. Borer J, Truter S, Gupta A, Herrold E, Carter J, Lee E, Pitlor L: Heart failure in aortic regurgitation: the role of primary fibrosis and its cellular and molecular pathophysiology. Adv Cardiol 2004;41:16–24.
  33. Kaprielian RR, Severs NJ: Dystrophin and the cardiomyocyte membrane cytoskeleton in the healthy and failing heart. Heart Fail Rev 2000;5:221–238.
  34. Frank D, Kuhn C, Katus HA, Frey N: The sarcomeric Z-disc: a nodal point in signalling and disease. J Mol Med 2006;84:446–468.
  35. Borer J, Truter S, Herrold E, Supino P, Carter J, Gupta A: The cellular and molecular basis of heart failure in regurgitant valvular diseases: the myocardial extracellular matrix as a building block for future therapy. Adv Cardiol 2002;39:7–14.
  36. Liu S, Magid N, Fox P, Goldfine S, Borer J: Fibrosis, myocyte degeneration and heart failure in chronic experimental aortic regurgitation. Cardiology 1998;90:101–109.
  37. Vatta M, Stetson SJ, Perez-Verdia A, Entman ML, Noon GP, Torre-Amione G, Bowles NE, Towbin JA: Molecular remodelling of dystrophin in patients with end-stage cardiomyopathies and reversal in patients on assistance-device therapy. Lancet 2002;359:936–941.
  38. Liang Q, Molkentin JD: Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models. J Mol Cell Cardiol 2003;35:1385–1394.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50